Search

Christopher W. Fulton

Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )

Most Active Art Unit
2855
Art Unit(s)
2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856
Total Applications
3373
Issued Applications
2875
Pending Applications
85
Abandoned Applications
419

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5131570 [patent_doc_number] => 20070207967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Peptide Inhibitors of Matrix Metalloproteinase Activity' [patent_app_type] => utility [patent_app_number] => 11/578793 [patent_app_country] => US [patent_app_date] => 2005-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10473 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207967.pdf [firstpage_image] =>[orig_patent_app_number] => 11578793 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/578793
Peptide Inhibitors of Matrix Metalloproteinase Activity Apr 20, 2005 Abandoned
Array ( [id] => 6967083 [patent_doc_number] => 20050233980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'CGRP-antagonist in combination with a serotonin-reuptake inhibitor for the treatment of migraine' [patent_app_type] => utility [patent_app_number] => 11/108985 [patent_app_country] => US [patent_app_date] => 2005-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5320 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233980.pdf [firstpage_image] =>[orig_patent_app_number] => 11108985 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/108985
CGRP-antagonist in combination with a serotonin-reuptake inhibitor for the treatment of migraine Apr 18, 2005 Abandoned
Array ( [id] => 4812772 [patent_doc_number] => 20080193403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Inducing And Maintaining Hair Color' [patent_app_type] => utility [patent_app_number] => 11/587594 [patent_app_country] => US [patent_app_date] => 2005-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1838 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193403.pdf [firstpage_image] =>[orig_patent_app_number] => 11587594 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/587594
Inducing And Maintaining Hair Color Apr 17, 2005 Abandoned
Array ( [id] => 404695 [patent_doc_number] => 07288527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-30 [patent_title] => 'Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester' [patent_app_type] => utility [patent_app_number] => 11/106201 [patent_app_country] => US [patent_app_date] => 2005-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5542 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/288/07288527.pdf [firstpage_image] =>[orig_patent_app_number] => 11106201 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/106201
Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester Apr 13, 2005 Issued
Array ( [id] => 4833906 [patent_doc_number] => 20080132453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Neuromedin B and somatostatin receptor agonists' [patent_app_type] => utility [patent_app_number] => 11/102981 [patent_app_country] => US [patent_app_date] => 2005-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14838 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132453.pdf [firstpage_image] =>[orig_patent_app_number] => 11102981 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/102981
Neuromedin B and somatostatin receptor agonists Apr 10, 2005 Abandoned
Array ( [id] => 121700 [patent_doc_number] => 07709444 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Echinocandin pharmaceutical formulations containing micelle-forming surfactants' [patent_app_type] => utility [patent_app_number] => 11/103798 [patent_app_country] => US [patent_app_date] => 2005-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11029 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709444.pdf [firstpage_image] =>[orig_patent_app_number] => 11103798 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/103798
Echinocandin pharmaceutical formulations containing micelle-forming surfactants Apr 10, 2005 Issued
Array ( [id] => 5441775 [patent_doc_number] => 20090093414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Hyaluronic Acid-Methotrexate Conjugate' [patent_app_type] => utility [patent_app_number] => 11/547158 [patent_app_country] => US [patent_app_date] => 2005-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25604 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093414.pdf [firstpage_image] =>[orig_patent_app_number] => 11547158 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/547158
Hyaluronic acid-methotrexate conjugate Mar 31, 2005 Issued
Array ( [id] => 7005746 [patent_doc_number] => 20050171059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Silanol enzyme inhibitors' [patent_app_type] => utility [patent_app_number] => 11/092316 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17124 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171059.pdf [firstpage_image] =>[orig_patent_app_number] => 11092316 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/092316
Silanol enzyme inhibitors Mar 28, 2005 Issued
Array ( [id] => 5259644 [patent_doc_number] => 20070213276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Epithelial Cell Growth Promoter' [patent_app_type] => utility [patent_app_number] => 10/594736 [patent_app_country] => US [patent_app_date] => 2005-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7145 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213276.pdf [firstpage_image] =>[orig_patent_app_number] => 10594736 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/594736
Epithelial cell growth promoter Mar 27, 2005 Issued
Array ( [id] => 4740691 [patent_doc_number] => 20080234344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Amino Acid and Peptide Conjugates of Arylalkylic Acids for Cosmetic Use' [patent_app_type] => utility [patent_app_number] => 10/593484 [patent_app_country] => US [patent_app_date] => 2005-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10163 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234344.pdf [firstpage_image] =>[orig_patent_app_number] => 10593484 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/593484
Amino Acid and Peptide Conjugates of Arylalkylic Acids for Cosmetic Use Mar 22, 2005 Abandoned
Array ( [id] => 6967073 [patent_doc_number] => 20050233970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Methods for treating long QT syndrome' [patent_app_type] => utility [patent_app_number] => 11/088462 [patent_app_country] => US [patent_app_date] => 2005-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4932 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233970.pdf [firstpage_image] =>[orig_patent_app_number] => 11088462 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/088462
Methods for treating long QT syndrome Mar 22, 2005 Abandoned
Array ( [id] => 7137922 [patent_doc_number] => 20050181987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Compositions and methods for treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/081198 [patent_app_country] => US [patent_app_date] => 2005-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18540 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181987.pdf [firstpage_image] =>[orig_patent_app_number] => 11081198 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/081198
Compositions and methods for treatment of cancer Mar 15, 2005 Abandoned
Array ( [id] => 7069065 [patent_doc_number] => 20050244448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Diagnosis and treatment of disorders of collagen and elastin metabolism' [patent_app_type] => utility [patent_app_number] => 11/082460 [patent_app_country] => US [patent_app_date] => 2005-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13060 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244448.pdf [firstpage_image] =>[orig_patent_app_number] => 11082460 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/082460
Diagnosis and treatment of disorders of collagen and elastin metabolism Mar 15, 2005 Abandoned
Array ( [id] => 418812 [patent_doc_number] => 07276484 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-02 [patent_title] => 'Dipeptide inhibitors of β-secretase' [patent_app_type] => utility [patent_app_number] => 11/075232 [patent_app_country] => US [patent_app_date] => 2005-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22859 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/276/07276484.pdf [firstpage_image] =>[orig_patent_app_number] => 11075232 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/075232
Dipeptide inhibitors of β-secretase Mar 7, 2005 Issued
Array ( [id] => 5435012 [patent_doc_number] => 20090169598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Treatment of bacterial infections' [patent_app_type] => utility [patent_app_number] => 10/586416 [patent_app_country] => US [patent_app_date] => 2005-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18792 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169598.pdf [firstpage_image] =>[orig_patent_app_number] => 10586416 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/586416
Treatment of bacterial infections Feb 27, 2005 Issued
Array ( [id] => 285640 [patent_doc_number] => 07550567 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Fibrinogen purification' [patent_app_type] => utility [patent_app_number] => 11/062432 [patent_app_country] => US [patent_app_date] => 2005-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 16054 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550567.pdf [firstpage_image] =>[orig_patent_app_number] => 11062432 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/062432
Fibrinogen purification Feb 22, 2005 Issued
Array ( [id] => 6960012 [patent_doc_number] => 20050215764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Biological polymer with differently charged portions' [patent_app_type] => utility [patent_app_number] => 11/060868 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 156730 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215764.pdf [firstpage_image] =>[orig_patent_app_number] => 11060868 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/060868
Biological polymer with differently charged portions Feb 17, 2005 Abandoned
Array ( [id] => 7005747 [patent_doc_number] => 20050171060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Phosphoramidates and methods therefor' [patent_app_type] => utility [patent_app_number] => 11/053024 [patent_app_country] => US [patent_app_date] => 2005-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15188 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171060.pdf [firstpage_image] =>[orig_patent_app_number] => 11053024 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/053024
Phosphoramidates and methods therefor Feb 7, 2005 Issued
Array ( [id] => 798075 [patent_doc_number] => 07427662 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-23 [patent_title] => 'Inhibition of angiogenesis and destruction of angiogenic vessels by apolipoprotein A-I and high density lipoprotein' [patent_app_type] => utility [patent_app_number] => 11/047852 [patent_app_country] => US [patent_app_date] => 2005-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5063 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/427/07427662.pdf [firstpage_image] =>[orig_patent_app_number] => 11047852 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/047852
Inhibition of angiogenesis and destruction of angiogenic vessels by apolipoprotein A-I and high density lipoprotein Jan 31, 2005 Issued
Array ( [id] => 13946 [patent_doc_number] => 07807781 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections' [patent_app_type] => utility [patent_app_number] => 11/044224 [patent_app_country] => US [patent_app_date] => 2005-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17194 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807781.pdf [firstpage_image] =>[orig_patent_app_number] => 11044224 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/044224
Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections Jan 27, 2005 Issued
Menu